Participants | MAF | ||||||||
---|---|---|---|---|---|---|---|---|---|
Risk region | SNP | Major allele | Minor allele | Cases | Controls | Cases | Controls | Per minor allele OR (95% CI)* | p Value |
1 | rs7726159 | C | A | 644 | 1171 | 0.33 | 0.34 | 0.97 (0.81–1.16) | 0.741 |
2 | rs451360 | C | A | 644 | 1171 | 0.24 | 0.22 | 1.20 (1.00–1.43) | 0.044 |
3 | rs2853677 | A | G | 644 | 1171 | 0.40 | 0.41 | 0.92 (0.79–1.08) | 0.320 |
4 | rs2736098 | C | T | 644 | 1171 | 0.23 | 0.28 | 0.75 (0.63–0.90) | 0.002 |
5 | rs13172201 | T | C | 644 | 1171 | 0.26 | 0.26 | 1.02 (0.84–1.25) | 0.808 |
6 | rs10069690 | C | T | 644 | 1171 | 0.23 | 0.24 | 1.00 (0.83–1.21) | 0.996 |
*Unconditional logistic regression model adjusted for age (continuous) and prospective cohort (HPFS, NHS, PHS, WHI-OS, WHS). OR reflects the OR per minor allele in an additive genetic model.
HPFS, Health Professionals Follow-up Study; MAF, minor allele frequency; NHS, Nurses’ Health Study; PHS, Physicians’ Health Study I; TERT, telomerase reverse transcriptase; WHI-OS, Women's Health Initiative Observational Study; WHS, Women's Health Study.